Abstract
The presence of prostate-specific antigen (PSA)-positive cells has previously been demonstrated in the peripheral blood of prostate cancer patients by flow cytometry (FC), but the identity of these cells has not been established. In this study, the reverse transcriptase polymerase chain reaction (RT-PCR) was compared with analytical FC in an attempt to detect and characterise these cells. Peripheral blood was obtained from 12 patients with newly diagnosed and untreated prostate cancer and five controls. Nine of the 12 patients with prostate cancer (75%) had circulating PSA-positive cells as shown by FC. Only one of those patients (11.1%) was found to express PSA mRNA by RT-PCR. The absence of PSA mRNA in the majority of samples showing PSA-positive cells suggests that they do not represent haematogenous micrometastases. PSA-positive cells in the blood could represent monocytes that express PSA, either following binding/phagocytosis of free serum PSA or phagocytosis of tumour cells.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 24 print issues and online access
$259.00 per year
only $10.79 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Fadlon, E., Rees, R., McIntyre, C. et al. Detection of circulating prostate-specific antigen-positive cells in patients with prostate cancer by flow cytometry and reverse transcription polymerase chain reaction. Br J Cancer 74, 400–405 (1996). https://doi.org/10.1038/bjc.1996.372
Issue Date:
DOI: https://doi.org/10.1038/bjc.1996.372
This article is cited by
-
Prostatakarzinomscreening durch einen neuen Marker auf der Basis zirkulierender Blutmakrophagen?
Der Urologe (2007)
-
Haematogenous cytokeratin 20 mRNA as a predictive marker for recurrence in oral cancer patients
British Journal of Cancer (1999)
-
Clinical usefulness of RT-PCR detection of hematogenous prostate cancer spread
Urological Research (1997)